Trump's acting attorney general moved to reclassify medical marijuana under federal law
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
18/20
Brand Signal
9/15
Depth
3/15
5-Axis Cultural Radar
The DOJ order immediately shifts FDA-approved and state-licensed cannabis products to Schedule III, lowering barriers to research and easing tax burdens on cannabis companies
